AltraVax acquires vaccine development technology package from Maxygen

AltraVax acquires vaccine development technology package from Maxygen AltraVax, Inc., a new, privately-held biopharmaceutical company, has acquired a vaccine development technology package from Maxygen, Inc. that gives AltraVax an exclusive license to develop vaccines for infectious diseases and is targeting... (Continue reading)